Clinical Trials Unit (CTU)

Keele Clinical Trials Unit specialises in the development and delivery of high-quality multicentre clinical trials, testing treatments and health services, as well as other high-quality clinical studies, including large epidemiological studies, in primary and secondary care settings with the aim of improving patient care.

Due to COVID-19 (Coronavirus), as of Monday 23rd March 2020, recruitment of patients to all of our active research studies has ceased. This is to allow our clinical colleagues to focus their care where it is most needed. Keele Clinical Trials Unit will be operating remotely. We are currently reviewing the trials we have open and are in contact with sponsors. The safety of our patients is always our priority. We apologise for any inconvenience caused at this challenging time. You can continue to contact us using individual staff email addresses or by using your usual study contact email address to contact study teams. Should you have any other queries or questions please use the general Keele CTU enquiry email -


For general enquiries please contact: 
Tel: 01782 732950

Privacy Notice
Keele Clinical Trials Unit is committed to protecting the privacy and security of the personal information of all participants in our research. For further information, please see the Keele University Privacy Notice for Research Participants.

Data Sharing Resources 

Keele University is a member of the UK Reproducibility Network and committed to the principles of the UK Concordat on Open Research Data. The School of Medicine and Keele Clinical Trials Unit have a longstanding commitment to sharing data from our studies to improve research reproducibility and to maximise benefits for patients, the wider public, and the health and care system. We encourage collaboration with those who collected the data, to recognise and credit their contributions.

The School of Medicine and Keele Clinical Trials Unit make data available to bona-fide researchers upon reasonable request via open or restricted access through a strict controlled access procedure. The release of data may be subject to a data use agreement (DUA) between the Sponsor and the third party requesting the data. In the first instance, data requests and enquiries should be directed to